Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860818 · ClinicalTrials.gov registry record · NA
Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 2,196
- Enrollment target
NCT03860818: Completed NA study, sponsored by VA Office of Research and Development.
NCT03860818 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 2,196 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03860818, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,196 participants
- Enrollment target
Study Summary
Medication safety issues in Veteran organ transplant recipients, including side effects and errors, are a major issue leading to graft failure and death. The causes of these events are complicated and involve fragmented care, communication breakdowns between the Veterans, providers and the different health care systems. This grant proposal seeks to improve medication safety within these high-risk Veterans, using two innovative components; the application of technology to leverage the massive amount of data contained within the electronic medical record in identifying Veterans with potential medication safety issues, coupled with a pharmacist-led intervention to improve the management and coordination of immunosuppression therapy. The completion of this prospective, multicenter, cluster randomized controlled clinical trial will provide evidence that these interventions can improve medication safety, clinical outcomes and costs and will be used to justify the dissemination of these interventions to all VAs caring for Veteran transplant recipients across the U.S.
Primary Outcome
24-month count hospitalization and emergency room visits compared between the intervention and usual care groups
Interventions
- OTHER Health services delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,196 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2021-06-14 |
| Phase | NA |
What the finished NCT03860818 record still lists
NCT03860818 is an interventional study that assigns participants to a tested intervention. Its 2,196 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% higher).
The record links to 0 conditions, and to 1 intervention - of which Health services delivery is the first listed.
NCT03860818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03860818 about?
NCT03860818 is a clinical study titled "Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention". Medication safety issues in Veteran organ transplant recipients, including side effects and errors, are a major issue leading to graft failure and death. The causes of these events are complicated and involve fragmented care, communication breakdowns between the Veterans, providers and the different...
What is the current status of trial NCT03860818?
This trial is currently completed. It is a NA study. The enrollment target is 2,196 participants. The study started on 2019-03-18. Estimated completion is 2021-06-14.
What interventions are being tested in trial NCT03860818?
The interventions under investigation include: Health services delivery (OTHER).
Who is sponsoring clinical trial NCT03860818?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03860818's enrollment target sits among peer trials
2,196 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI